+91-22-48913909
फिन्कॅश »म्युच्युअल फंड »2018 साठी सर्वोत्कृष्ट परफॉर्मिंग सेक्टर फंड
Table of Contents
- कामगिरीवर आधारित 2019 साठी 10 परफॉर्मिंग सेक्टर म्युच्युअल फंड
- 2019 साठी सर्वोत्कृष्ट परफॉर्मिंग सेक्टर फंड
Top 10 Equity - Sectoral Funds
2019 साठी सर्वोत्कृष्ट 10 परफॉर्मिंग सेक्टर फंड
क्षेत्रम्युच्युअल फंड एखाद्या विशिष्ट क्षेत्रातील कंपन्यांच्या इक्विटी शेअर्समध्ये त्यांच्या फंड पैशांचा प्रमुख हिस्सा गुंतवणूकीच्या योजनेचा संदर्भ घ्या. या योजना ज्यांचा शोध घेत आहेत त्यांच्याद्वारे मागवल्या जातातउच्च परतावा त्यांच्या गुंतवणूकीसहउच्च धोका भूक. म्युच्युअल फंड सामान्यत: त्यांच्या योजना ऑफर करतात अशा काही क्षेत्रांमध्ये पायाभूत सुविधा, औषधनिर्माण, बँकिंग आणि वित्तीय सेवा आणि नैसर्गिक संसाधने आणि नवीन ऊर्जा यांचा समावेश आहे. सन २०१ 2019 साठी क्षेत्रीय निधीची कामगिरी चांगली होती. अर्थव्यवस्थेच्या घडामोडींसह, बर्‍याच क्षेत्रिय फंडांनी त्यांच्या गुंतवणूकीवर सकारात्मक परतावा मिळविला आहे. तर, त्यांच्या कामगिरीच्या (परतावा) आधारे आपण 2019 च्या वर्षातील काही वरच्या आणि सर्वोत्कृष्ट 10 परफॉरमिंग सेक्टर म्युच्युअल फंडाकडे पाहूया.
Talk to our investment specialist
कामगिरीवर आधारित 2019 साठी 10 परफॉर्मिंग सेक्टर म्युच्युअल फंड
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹50.6391
↑ 0.05 ₹1,053 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹294.925
↑ 1.74 ₹1,099 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹436.019
↓ -2.09 ₹3,849 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.7239
↑ 0.16 ₹1,282 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹51.38
↓ -0.03 ₹1,749 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹255.408
↑ 0.45 ₹7,200 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹44.0513
↓ -0.09 ₹1,153 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹162.6
↑ 0.51 ₹932 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹522.424
↑ 2.97 ₹8,569 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹65.59
↑ 0.01 ₹1,607 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 23 Jul 25
2019 साठी सर्वोत्कृष्ट परफॉर्मिंग सेक्टर फंड
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.8% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (23 Jul 25) ₹50.6391 ↑ 0.05 (0.10 %) Net Assets (Cr) ₹1,053 on 30 Jun 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio -0.02 Information Ratio 0.45 Alpha Ratio 0.77 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,983 30 Jun 22 ₹17,801 30 Jun 23 ₹22,663 30 Jun 24 ₹41,985 30 Jun 25 ₹42,989 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 2.7% 3 Month 13.2% 6 Month 8% 1 Year 1.2% 3 Year 30.9% 5 Year 32.1% 10 Year 15 Year Since launch 9.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.7 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for LIC MF Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 51.57% Basic Materials 9.67% Consumer Cyclical 7.9% Utility 6.15% Financial Services 5.44% Real Estate 2.87% Communication Services 2.32% Technology 2.25% Health Care 0.42% Energy 0.4% Asset Allocation
Asset Class Value Cash 10.86% Equity 89.14% Top Securities Holdings / Portfolio
Name Holding Value Quantity Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹44 Cr 94,287 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹39 Cr 452,572
↑ 44,445 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | TATAPOWER3% ₹28 Cr 724,927 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹26 Cr 624,435
↑ 87,219 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | BHEL2% ₹24 Cr 913,126
↓ -149,073 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER2% ₹23 Cr 305,924
↓ -26,125 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD2% ₹23 Cr 571,332 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND2% ₹22 Cr 67,407
↑ 559 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹22 Cr 96,061
↓ -30,853 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 397,031
↓ -79,438 2. UTI Healthcare Fund
CAGR/Annualized return of 15.1% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (23 Jul 25) ₹294.925 ↑ 1.74 (0.59 %) Net Assets (Cr) ₹1,099 on 30 Jun 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.75 Information Ratio -0.29 Alpha Ratio 1.14 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,774 30 Jun 22 ₹13,373 30 Jun 23 ₹15,783 30 Jun 24 ₹22,500 30 Jun 25 ₹27,347 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 5.8% 3 Month 7.7% 6 Month 5.5% 1 Year 18.5% 3 Year 26.2% 5 Year 21.7% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Data below for UTI Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 96.34% Basic Materials 0.99% Asset Allocation
Asset Class Value Cash 2.67% Equity 97.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹111 Cr 661,016
↓ -11,873 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹59 Cr 400,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹50 Cr 396,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹46 Cr 80,283
↑ 520 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM4% ₹43 Cr 172,829 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹40 Cr 275,250 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹37 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS3% ₹33 Cr 465,000 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS3% ₹32 Cr 204,451
↓ -8,479 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.6% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (22 Jul 25) ₹436.019 ↓ -2.09 (-0.48 %) Net Assets (Cr) ₹3,849 on 30 Jun 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.87 Information Ratio 0.37 Alpha Ratio 2.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,902 30 Jun 22 ₹13,774 30 Jun 23 ₹17,755 30 Jun 24 ₹24,634 30 Jun 25 ₹29,799 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 4.4% 3 Month 4.1% 6 Month 5.1% 1 Year 19.2% 3 Year 27.9% 5 Year 23.9% 10 Year 15 Year Since launch 15.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 90.06% Basic Materials 6.02% Asset Allocation
Asset Class Value Cash 3.92% Equity 96.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹470 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹273 Cr 412,222
↑ 12,222 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹236 Cr 2,100,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹178 Cr 300,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA5% ₹176 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN4% ₹164 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹123 Cr 1,800,000
↓ -234,372 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS3% ₹119 Cr 1,680,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹118 Cr 1,000,000 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.4% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (23 Jul 25) ₹30.7239 ↑ 0.16 (0.53 %) Net Assets (Cr) ₹1,282 on 30 Jun 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.47 Information Ratio 0.73 Alpha Ratio 2.42 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,403 30 Jun 22 ₹13,787 30 Jun 23 ₹16,370 30 Jun 24 ₹23,471 30 Jun 25 ₹27,032 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 4.5% 3 Month 3.7% 6 Month 1.8% 1 Year 11.2% 3 Year 23.8% 5 Year 21.5% 10 Year 15 Year Since launch 12.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.23 Yr. Rajat Srivastava 16 Sep 24 0.71 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 88.47% Basic Materials 2.37% Asset Allocation
Asset Class Value Cash 9.16% Equity 90.84% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹143 Cr 854,300 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹77 Cr 111,255
↑ 10,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA6% ₹72 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹71 Cr 615,100 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB6% ₹69 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS5% ₹60 Cr 855,100 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN5% ₹59 Cr 303,240 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹54 Cr 956,991 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA3% ₹40 Cr 274,871 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY3% ₹39 Cr 311,555 5. IDFC Infrastructure Fund
CAGR/Annualized return of 12.1% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (23 Jul 25) ₹51.38 ↓ -0.03 (-0.06 %) Net Assets (Cr) ₹1,749 on 30 Jun 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio -0.3 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹18,739 30 Jun 22 ₹17,927 30 Jun 23 ₹25,177 30 Jun 24 ₹46,897 30 Jun 25 ₹45,046 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 2.7% 3 Month 6.9% 6 Month 7.9% 1 Year -6.7% 3 Year 31.5% 5 Year 34.5% 10 Year 15 Year Since launch 12.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.35 Yr. Ritika Behera 7 Oct 23 1.65 Yr. Gaurav Satra 7 Jun 24 0.98 Yr. Data below for IDFC Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 54.62% Utility 11.75% Basic Materials 8.33% Communication Services 4.62% Energy 3.78% Financial Services 2.9% Technology 2.63% Consumer Cyclical 2.13% Health Care 1.81% Real Estate 0.31% Asset Allocation
Asset Class Value Cash 6.61% Equity 93.39% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹80 Cr 443,385 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹68 Cr 4,797,143 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹67 Cr 183,173 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹64 Cr 452,706 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹61 Cr 330,018 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | ULTRACEMCO3% ₹57 Cr 50,452 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹55 Cr 1,431,700 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹52 Cr 365,137 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹46 Cr 12,400,122 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 30 Apr 15 | AHLUCONT3% ₹45 Cr 462,949
↓ -5,288 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.6% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (23 Jul 25) ₹255.408 ↑ 0.45 (0.18 %) Net Assets (Cr) ₹7,200 on 30 Jun 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio -0.09 Information Ratio 1.71 Alpha Ratio -1.73 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,895 30 Jun 22 ₹15,964 30 Jun 23 ₹21,557 30 Jun 24 ₹37,944 30 Jun 25 ₹39,360 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 3.5% 3 Month 6.8% 6 Month 7.6% 1 Year 4.4% 3 Year 32.2% 5 Year 29.9% 10 Year 15 Year Since launch 13.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.31 Yr. R. Janakiraman 1 Apr 13 12.18 Yr. Sandeep Manam 18 Oct 21 3.62 Yr. Data below for Franklin India Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 18.51% Consumer Cyclical 15.31% Technology 11.09% Health Care 10.66% Basic Materials 8.13% Communication Services 6.72% Energy 6.29% Consumer Defensive 5.33% Industrials 4.34% Real Estate 2.14% Utility 1.18% Asset Allocation
Asset Class Value Cash 10.29% Equity 89.71% Top Securities Holdings / Portfolio
Name Holding Value Quantity Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE6% ₹432 Cr 3,038,968 HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹398 Cr 2,043,971 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 30 Jun 24 | HINDUNILVR4% ₹263 Cr 1,121,657 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹249 Cr 1,342,233 Intellect Design Arena Ltd (Technology)
Equity, Since 30 Jun 24 | INTELLECT4% ₹244 Cr 2,076,823 Axis Bank Ltd (Financial Services)
Equity, Since 30 Apr 25 | AXISBANK3% ₹232 Cr 1,948,029 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹190 Cr 637,966 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | MPHASIS3% ₹182 Cr 710,533 APL Apollo Tubes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | APLAPOLLO3% ₹181 Cr 998,385 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹179 Cr 12,833,401 7. L&T Business Cycles Fund
CAGR/Annualized return of 14.5% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (23 Jul 25) ₹44.0513 ↓ -0.09 (-0.20 %) Net Assets (Cr) ₹1,153 on 30 Jun 25 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio 0.16 Information Ratio 0.95 Alpha Ratio 3.27 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,091 30 Jun 22 ₹16,145 30 Jun 23 ₹21,228 30 Jun 24 ₹32,455 30 Jun 25 ₹35,049 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 1.6% 3 Month 8.9% 6 Month 12% 1 Year 7.1% 3 Year 24.9% 5 Year 26.9% 10 Year 15 Year Since launch 14.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Gautam Bhupal 1 Jun 23 2 Yr. Sonal Gupta 1 Jun 23 2 Yr. Data below for L&T Business Cycles Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 31.05% Industrials 27.8% Consumer Cyclical 18.9% Basic Materials 10.99% Energy 6% Technology 1.15% Real Estate 0.87% Asset Allocation
Asset Class Value Cash 3.24% Equity 96.76% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK6% ₹61 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE5% ₹57 Cr 401,700 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX5% ₹57 Cr 85,600 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | TRENT5% ₹54 Cr 95,680 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK4% ₹48 Cr 246,800 Power Mech Projects Ltd (Industrials)
Equity, Since 31 Oct 22 | POWERMECH3% ₹28 Cr 90,800 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 31 Jan 15 | AHLUCONT2% ₹27 Cr 274,908 PB Fintech Ltd (Financial Services)
Equity, Since 31 Dec 23 | 5433902% ₹26 Cr 149,200 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 22 | BEL2% ₹26 Cr 674,300 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | PFC2% ₹24 Cr 603,200 8. Canara Robeco Infrastructure
CAGR/Annualized return of 15.3% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (23 Jul 25) ₹162.6 ↑ 0.51 (0.31 %) Net Assets (Cr) ₹932 on 30 Jun 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio -0.17 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,402 30 Jun 22 ₹17,983 30 Jun 23 ₹24,047 30 Jun 24 ₹41,538 30 Jun 25 ₹41,825 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 2.2% 3 Month 8.5% 6 Month 11.3% 1 Year 2.4% 3 Year 28.7% 5 Year 32.1% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 4.01 Yr. Shridatta Bhandwaldar 29 Sep 18 6.76 Yr. Data below for Canara Robeco Infrastructure as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 46.57% Utility 12.3% Basic Materials 10.51% Energy 8.34% Financial Services 6.29% Technology 3.87% Communication Services 2.8% Consumer Cyclical 2.78% Real Estate 1.51% Asset Allocation
Asset Class Value Cash 4.51% Equity 95.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT7% ₹62 Cr 169,401
↑ 15,000 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹38 Cr 264,250 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | NTPC4% ₹36 Cr 1,066,480 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL4% ₹35 Cr 919,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO3% ₹31 Cr 58,250 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | TATAPOWER3% ₹31 Cr 785,000 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN3% ₹30 Cr 370,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | POWERGRID3% ₹28 Cr 957,546 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222753% ₹28 Cr 123,066 Solar Industries India Ltd (Basic Materials)
Equity, Since 28 Feb 25 | SOLARINDS3% ₹27 Cr 16,812 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.6% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (23 Jul 25) ₹522.424 ↑ 2.97 (0.57 %) Net Assets (Cr) ₹8,569 on 30 Jun 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 0.57 Information Ratio -0.55 Alpha Ratio -2.16 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,184 30 Jun 22 ₹13,821 30 Jun 23 ₹16,792 30 Jun 24 ₹23,641 30 Jun 25 ₹27,501 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 3.3% 3 Month 4.7% 6 Month 4.9% 1 Year 11.9% 3 Year 24.2% 5 Year 21.4% 10 Year 15 Year Since launch 20.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.18 Yr. Kinjal Desai 25 May 18 7.02 Yr. Data below for Nippon India Pharma Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 98.58% Asset Allocation
Asset Class Value Cash 1.42% Equity 98.58% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA13% ₹1,050 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹793 Cr 1,198,808
↓ -100,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | LUPIN6% ₹486 Cr 2,483,991 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | CIPLA6% ₹469 Cr 3,200,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹458 Cr 3,662,170 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹446 Cr 648,795 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹351 Cr 3,627,277 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO4% ₹311 Cr 943,731
↓ -68,190 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹271 Cr 2,831,564 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 30 Jun 17 | NH3% ₹245 Cr 1,406,946
↓ -19,224 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 11.2% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (23 Jul 25) ₹65.59 ↑ 0.01 (0.02 %) Net Assets (Cr) ₹1,607 on 30 Jun 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio -0.22 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,282 30 Jun 22 ₹17,073 30 Jun 23 ₹22,438 30 Jun 24 ₹40,585 30 Jun 25 ₹39,596 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 2.3% 3 Month 9.7% 6 Month 8.4% 1 Year -0.3% 3 Year 28.9% 5 Year 31.1% 10 Year 15 Year Since launch 11.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.82 Yr. Sagar Gandhi 1 Mar 25 0.33 Yr. Data below for Invesco India Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 57.36% Basic Materials 9.15% Consumer Cyclical 7.94% Utility 6.4% Communication Services 6.18% Health Care 4.2% Technology 3.01% Energy 2.62% Real Estate 1.93% Asset Allocation
Asset Class Value Cash 1.03% Equity 98.97% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL6% ₹97 Cr 521,351 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | SUPREMEIND4% ₹62 Cr 150,390
↑ 6,126 Delhivery Ltd (Industrials)
Equity, Since 31 Aug 24 | 5435294% ₹61 Cr 1,698,708
↑ 150,858 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | POWERGRID4% ₹57 Cr 1,975,592 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹55 Cr 35,841
↓ -1,861 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 30 Nov 24 | POWERINDIA3% ₹53 Cr 27,373
↓ -5,039 Indian Railway Catering And Tourism Corp Ltd (Industrials)
Equity, Since 30 Apr 24 | IRCTC3% ₹52 Cr 683,788
↑ 9,038 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP3% ₹49 Cr 71,172 Jyoti CNC Automation Ltd (Industrials)
Equity, Since 31 Jan 24 | JYOTICNC3% ₹49 Cr 377,664
↓ -40,765 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Sep 22 | DIXON3% ₹47 Cr 32,076
↓ -3,331
येथे प्रदान केलेली माहिती अचूक आहे हे सुनिश्चित करण्यासाठी सर्व प्रयत्न केले गेले आहेत. तथापि, डेटाच्या शुद्धतेबद्दल कोणतीही हमी दिलेली नाही. कृपया कोणतीही गुंतवणूक करण्यापूर्वी योजना माहिती दस्तऐवजासह सत्यापित करा.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved